CLRB(CLRB)
CLRB
Q4 2026 EPS Estimate
$-0.56
Nov 12, 2026 · Reports before open
Revenue Estimate
$17M
FY2029E EPS$0.80
FY2030E EPS$2.31
Analyst Sentiment
Wall St. Consensus
Buy7 analysts·Limited coverage
75
Score
7 Buy (100%)0 Hold (0%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
7100%
Hold
00%
Sell
00%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price Target Expectations
Bear
$11.00
+352.7%
Consensus
$11.00
+352.7%
Bull
$11.00
+352.7%
12-Month Target Range7 analysts
$11.00$11.00$11.00
Current $2.43Consensus
Current Price
$2.43
Upside to Consensus
$8.57
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
Earnings & Revenue Estimates
Forward Growth Estimates (YoY)
FY2027
Rev+101.28%
EPS—
FY2028
Rev+506.41%
EPS—
FY2029
Rev+113.54%
EPS—
Raw consensus estimates (low / average / high) from covering analysts.
Annual
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $4M | $8M | $46M | $99M | $155M |
| Low | $1M | $3M | $12M | $35M | $55M |
| High | $6M | $11M | $72M | $148M | $231M |
| EBITDA Avg | $-6M | $-5M | $-1M | $3M | $8M |
| Low | $-7M | $-5M | $-1M | $517,366 | $1M |
| High | $-5M | $-4M | $-1M | $4M | $13M |
| EBIT Avg | $-6M | $-5M | $-1M | $3M | $8M |
| Low | $-7M | $-6M | $-2M | $429,877 | $1M |
| High | $-6M | $-4M | $-1M | $4M | $13M |
| Net Income Avg | $-6M | $-5M | $-1M | $2M | $6M |
| Low | $-7M | $-6M | $-2M | $339,603 | $982,735 |
| High | $-6M | $-4M | $-1M | $3M | $10M |
| EPS Avg | $-2.43 | $-1.92 | $-0.56 | $0.80 | $2.31 |
| Low | $-2.65 | $-2.16 | $-0.61 | $0.13 | $0.38 |
| High | $-2.14 | $-1.43 | $-0.52 | $1.31 | $3.79 |
| Analysts (Rev / EPS) | 4 / 3 | 3 / 3 | 4 / 2 | 2 / 1 | 2 / 1 |
Quarterly
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $17M | $25M | — | — | $2M | $4M |
| Low | $17M | $25M | — | — | $2M | $4M |
| High | $17M | $25M | — | — | $2M | $4M |
| EBITDA Avg | $-7M | $-7M | — | — | $-7M | $-8M |
| Low | $-7M | $-8M | — | — | $-7M | $-8M |
| High | $-6M | $-5M | — | — | $-7M | $-8M |
| EBIT Avg | $-7M | $-7M | — | — | $-7M | $-8M |
| Low | $-7M | $-8M | — | — | $-7M | $-8M |
| High | $-6M | $-5M | — | — | $-7M | $-8M |
| Net Income Avg | $-7M | $-7M | $-6M | $-7M | $-7M | $-8M |
| Low | $-7M | $-8M | $-6M | $-7M | $-7M | $-8M |
| High | $-6M | $-5M | $-6M | $-7M | $-7M | $-8M |
| EPS Avg | $-0.56 | $-0.53 | $-0.51 | $-0.61 | $-0.61 | $-0.61 |
| Low | $-0.60 | $-0.62 | $-0.51 | $-0.61 | $-0.61 | $-0.61 |
| High | $-0.51 | $-0.45 | $-0.51 | $-0.61 | $-0.61 | $-0.61 |
| Analysts (Rev / EPS) | 1 / 3 | 1 / 3 | — / 1 | — / 1 | 1 / 1 | 1 / 1 |
